Salim Yazji - Net Worth and Insider Trading
Salim Yazji Net Worth
The estimated net worth of Salim Yazji is at least $4,336 dollars as of 2024-12-27. Salim Yazji is the Chief Medical Officer of Oncternal Therapeutics Inc and owns about 8,234 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $4,336. Details can be seen in Salim Yazji's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Salim Yazji has not made any transactions after 2023-04-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Salim Yazji
Salim Yazji Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Salim Yazji owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Salim Yazji’s form 4 insider trades.
Insider Ownership Summary of Salim Yazji
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2023-04-14 | Chief Medical Officer |
Salim Yazji Latest Holdings Summary
Salim Yazji currently owns a total of 1 stock. Salim Yazji owns 8,234 shares of Oncternal Therapeutics Inc (ONCT) as of April 14, 2023, with a value of $4,336.
Latest Holdings of Salim Yazji
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2023-04-14 | 8,234 | 0.53 | 4,336 |
Holding Weightings of Salim Yazji
Salim Yazji Form 4 Trading Tracker
According to the SEC Form 4 filings, Salim Yazji has made a total of 2 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 1,250 shares on April 14, 2023, which cost Salim Yazji around $7,250.
Insider Trading History of Salim Yazji
- 1
Salim Yazji Trading Performance
GuruFocus tracks the stock performance after each of Salim Yazji's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Salim Yazji is -0.27%. GuruFocus also compares Salim Yazji's trading performance to market benchmark return within the same time period. The performance of stocks bought by Salim Yazji within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Salim Yazji's insider trading performs compared to the benchmark.
Performance of Salim Yazji
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.18 | | | | | |
| Relative Return to S&P 500(%) | 0.68 | | | | | |
Salim Yazji Ownership Network
Salim Yazji Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Salim Yazji is the Chief Medical Officer of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and director & President & CEO James B Breitmeyer .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Salim Yazji made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , and a net purchase of 980 shares made by David F Hale .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 10,980 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Salim Yazji Mailing Address
Above is the net worth, insider trading, and ownership report for Salim Yazji. You might contact Salim Yazji via mailing address: 12230 El Camino Real, Suite 300, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
